Lorusso D, Raspagliesi F, Ronzulli D, Valabrega G, et al. Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial. J Clin Oncol 2024 Feb 5:JCO2301225. doi: 10.1200/JCO.23.01225.
PMID: 38315944